Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • CARLSBAD, Calif. – Thermo Fisher Scientific Launches 3,000 L and 5,000 L HyPerforma DynaDrive Single-Use Bioreactors (S.U.B.s) for Cell Culture Production

    Mar 10, 2021, 10:10 AM by
    Full story
  • SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines

    Mar 10, 2021, 10:10 AM by
    SB3000 is to receive grant funding from the Danish Innovation Fund to support its continuous manufacturing enabling technology for medicine production.
    Full story
  • Further European expansion for G&L Scientific

    Mar 10, 2021, 10:10 AM by
    Regulatory Affairs experts, G&L Scientific, have announced further expansion in Europe with new dedicated client services in Spain, Italy, Germany and France.
    Full story
  • VERICHEM LABORATORIES ANNOUNCES EXTENDED STABILITY CLAIMS FOR ITS AMMONIA/IRON CLINICAL REFERENCE STANDARD

    Mar 10, 2021, 10:10 AM by
    VERICHEM LABORATORIES has announced that the open vial stability claim on its combined Ammonia/Iron Standard Kit has been extended to an exceptional twenty-four (24) months, making it ideal for numerous calibration verification events, or test system troubleshooting.
    Full story
  • Northeast Georgia Health System Elevates Its Digital Consumer Experience with Self-Service Capabilities from Kyruus

    Mar 10, 2021, 10:10 AM by
    Full story
  • Standigm Secures $44.5 M in Pre-IPO Funding Round

    Mar 10, 2021, 10:05 AM by
    Standigm, a leading AI-based drug discovery company, raised $44.5 M in a Pre-IPO round to go public on the Korea Exchange later in 2021.
    Full story
  • See Your Data: Collaborative Dictionary Authoring

    Mar 9, 2021, 01:00 AM by User Not Found
    Bio-IT World | The foundation of a data commons is the data dictionary—the map or model populated with all of the data within an organization and the relationships between them. The hardest part of FAIR is the “I”—interoperability, says Bill Van Etten, senior scientific consultant at BioTeam. The data dictionary is what brings you from FAR to FAIR.
    Full story
  • Omics, Methylation, AI-Driven Discovery, Online Education: News and Products for February

    Mar 8, 2021, 01:00 AM by User Not Found
    Bio-IT World | New products and company updates from around Bio-IT including Seven Bridges’ partnership with Pfizer, Illumina’s Russian approval, new methylation detection platform from Twist, and more.
    Full story
  • Nanotechnology-Based Vaccine Candidate, Blood Type A Raises Risk, Neanderthal-Derived Protein Offers Protection: COVID-19 Updates

    Mar 5, 2021, 01:00 AM by User Not Found
    Bio-IT World I Variant that emerged in the UK could be more transmissible, SARS-CoV-2 may be particularly attracted to blood group A respiratory cells, a balanced T cell response is key to clearing virus without symptoms, and out-of-place large bone marrow cells responsible for brain fog. Plus: Heart muscle cells a target and could lead to cell death, interfere with heart muscle contraction and MIS-C patients have highly activated immune systems that are similar to adult COVID-19 patients.
    Full story
  • Spatial Surge: AGBT Updates On Single-Cell and Spatial Genomics, In Situ Analysis, More

    Mar 4, 2021, 01:00 AM by User Not Found
    Bio-IT World | A host of sponsors and vendor companies attended the virtual AGBT General Meeting this week. Through sponsored talks and even more poster sessions, vendor companies shared their latest work and technology developments and made product announcements.
    Full story
  • CRISPR For COVID-19: Approaches To Speeding Therapeutic Discovery

    Mar 3, 2021, 01:00 AM by User Not Found
    Bio-IT World | Neville Sanjana from the New York Genome Center and NYU turned his attention to COVID-19 early in the pandemic. For several years, his lab has focused on using CRISPR to identify which regions of the genome drive disease. Last year, he applied that expertise to using genome-wide CRISPR screens to look for COVID-19 risk factors.
    Full story
  • Building A Telomere-to-Telomere Human Pangenome Reference

    Mar 2, 2021, 14:37 PM by User Not Found
    Bio-IT World | Our current version of the human reference genome does not adequately represent genetic diversity in the human population, Karen Miga told the virtual audience at this week’s AGBT General Meeting. The Human Pangenome Reference Consortium and the Telomere-to-Telomere Consortium are working to change that.
    Full story
  • Updates To All of Us, First Genomic Results Returned To Participants

    Mar 1, 2021, 16:51 PM by User Not Found
    Bio-IT World | Josh Denny, CEO of NIH’s All of Us program, gave an update on the population sequencing program in the opening session of the virtual AGBT General Meeting this week.
    Full story
  • Evolving Risks, Insecure Defaults, Watering Hole Threats: New Research from Accurics Uncovers Developing Sources of Cloud Risk

    Mar 1, 2021, 09:38 AM by
    Full story
  • Formulationbio: A Leading Manufacturer of Excipients for Pharmaceutical Preparation

    Mar 1, 2021, 09:38 AM by
    A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, Formulationbio supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, fillers, stabilizers and so on.
    Full story
  • Caroline O’Connor becomes new CCO of rare disease healthtech Raremark® amid rapid growth

    Mar 1, 2021, 09:38 AM by
    Full story
  • Global rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTO

    Mar 1, 2021, 09:38 AM by
    Full story
  • Europital board forewarns that clinical deficits to slow biotech development in 2021

    Mar 1, 2021, 09:38 AM by
    Full story
  • Ashfield Healthcare Communications rebrands as Ashfield Health, launches two new global agencies and appoints former McCann Health Americas head as Global President.

    Mar 1, 2021, 09:38 AM by
    • Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network. • Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency. • Ashfield Health’s 14 medical and scientific communications agencies come together to create Ashfield MedComms, a new 700 strong global powerhouse. • Ashfield Health agencies unified by common brand identity and shared new purpose to ‘make it matter’
    Full story
  • John Snow Labs Announces Inaugural Healthcare NLP Summit in Response to Industry Demand

    Mar 1, 2021, 09:38 AM by
    John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.
    Full story
  • «
  • 181
  • 182
  • 183 (current)
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy